Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep;55(3):585-596.
doi: 10.3892/ijo.2019.4850. Epub 2019 Jul 29.

Long non‑coding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review)

Lin Jiang  1 , Zheng Li  2 , Ranran Wang  1
Affiliations
Review

Long non‑coding RNAs in lung cancer: Regulation patterns, biologic function and diagnosis implications (Review)

Lin Jiang et al. Int J Oncol. 2019 Sep.

Abstract

Lung cancer is the most common malignancy with the highest mortality worldwide. Emerging research has demonstrated that long non‑coding RNAs (lncRNAs), a key genomic product, are commonly dysregulated in lung cancer and have significant functions in lung cancer initiation, progression and therapeutic response. lncRNAs may interact with DNA, RNA or proteins, as tumor suppressor genes or oncogenes, to regulate gene expression and cell signaling pathways. In the present review, first a summary was presented of the causal effects of dysregulated lncRNAs in lung cancer. Next, the function and specific mechanisms of lncRNA‑mediated tumorigenesis, metastasis and drug resistance in lung cancer were discussed. Finally, the potential roles of lncRNAs as biomarkers for lung cancer were explored.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic plot of regulation patterns of dysregulated lncRNAs in lung cancer. (A) Chemical compounds and hypoxia affect lncRNA expression to promote cancer progression. (B) Changes in epigenetic modification of lncRNAs can regulate the development of lung cancer. (C) Various transcription factors can interact with lncRNAs to activate or inhibit their transcription, subsequently affecting cancer progression. lncRNA, long non-coding RNA.
Figure 2
Figure 2
Roles of lncRNA-mediated regulatory pathways in proliferation of lung cancer cells. According to their functions, lncRNAs were classified into two categories: Oncogenic lncRNAs (orange) are upregulated in lung cancer, enhancing growth and proliferation of lung cancer cells; whereas tumor suppressor lncRNAs (purple) are downregulated in lung cancer, inhibiting proliferation. lncRNA, long non-coding RNA.
Figure 3
Figure 3
Roles of lncRNA-mediated regulatory pathways in invasion and metastasis of lung cancer. lncRNAs act as sponges for miRNAs or regulate their downstream target genes, thereby promoting invasion and metastasis of lung cancer cells. lncRNA, long non-coding RNA; miRNA, microRNA.
Figure 4
Figure 4
lncRNAs mediate drug and radiation resistance. Tumor suppressor lncRNAs can regulate EGFR, IGF-1R, the Wnt signaling pathway and p53 to inhibit resistance of cancer cells towards drug and radiation therapy. Oncogenic lncRNAs promote resistance via multiple pathways, target genes and miRNAs. lncRNA, long non-coding RNA; EGFR, epidermal growth factor receptor; IGF-1R, insulin-like growth factor 1 receptor; miRNA, microRNA.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30. doi: 10.3322/caac.21442. - DOI - PubMed
    1. Cheng TY, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME. The International epidemiology of lung cancer: Latest trends, disparities, and tumor characteristics. J Thorac Oncol. 2016;11:1653–1671. doi: 10.1016/j.jtho.2016.05.021. - DOI - PMC - PubMed
    1. Behera M, Owonikoko TK, Gal AA, Steuer CE, Kim S, Pillai RN, Khuri FR, Ramalingam SS, Sica GL. Lung adenocarcinoma staging using the 2011 IASLC/ATS/ERS classification: A pooled analysis of adenocarcinoma in situ and minimally invasive adenocarcinoma. Clin Lung Cancer. 2016;17:e57–e64. doi: 10.1016/j.cllc.2016.03.009. - DOI - PubMed
    1. Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: A heterogeneous set of diseases. Nat Rev Cancer. 2014;14:535–546. doi: 10.1038/nrc3775. - DOI - PMC - PubMed
    1. Xue K, Li FF, Chen YW, Zhou YH, He J. Body mass index and the risk of cancer in women compared with men: A meta-analysis of prospective cohort studies. Eur J Cancer Prev. 2016;26:94–105. doi: 10.1097/CEJ.0000000000000231. - DOI - PubMed

MeSH terms